跳至主要内容
临床试验/NL-OMON37648
NL-OMON37648已完成不适用

Sorafenib pharmacokinetics in non small cell lung cancer patients: an in;vivo study using positron emission tomography - [11C]sorafenib kinetics in NSCLC patients

Vrije Universiteit Medisch Centrum0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients age of 18-70 years;
  • Patients with advanced non small cell lung cancer harboring a K-Ras mutation;
  • Life expectancy of at least 12 weeks;
  • Malignant lesion of at least 1.5 cm diameter within the chest as;
  • measured by CT;
  • Performance status Karnofsky index >60%;
  • Laboratory requirements;
  • Written informed consent

排除标准

  • Claustrophobia;
  • Pregnant or lactating patients;
  • Patients having metal implants (e.g. pacemakers);
  • Concurrent or previous treatment with experimental drugs

研究者

相似试验

已完成
不适用
Onderzoek naar het effect van OATP1B blokkade op de stofwisseling van sorafenib (Nexavar®) bij volwassen patiënten met kanker.Solid tumors treated with sorafenib (Nexavar®) mono therapy.
NL-OMON23851Erasmus Medical Center; Department of Medical Oncology9
已完成
2 期
First line Therapy by Sorafenib for Lung Metastases Patients in Renal Cell CarcinomaRenal cell carcinoma
JPRN-UMIN000005090Kobe University Graduate school of Medicine100
进行中(未招募)
不适用
Studying the influence of rifampicin administration on the processing of sorafenib in adult patients with cancerCancer
EUCTR2013-001525-10-NLErasmus MC
已完成
不适用
Studying the metabolism of sorafenib (Nexavar®) by OATP1B blockage in adult cancer patients
NL-OMON38631Erasmus MC, Universitair Medisch Centrum Rotterdam9
进行中(未招募)
1 期
Evaluation of Sorafenib in combination with local micro-therapy guided by Gd-EOB-DTPA enhanced MRI in patients with inoperable hepatocellular carcinoma - SORAMICCarcinoma hepatocelular (CHC)Patients with Hepatocellular carcinoma (liver-predominant disease)MedDRA version: 12.1Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableMedDRA version: 12.1Level: LLTClassification code 10019829Term: Hepatocellular carcinoma recurrentMedDRA version: 12.1Level: LLTClassification code 10019830Term: Hepatocellular carcinoma resectableMedDRA version: 12.1Level: LLTClassification code 10049010Term: Carcinoma hepatocellular
EUCTR2009-012576-27-SIMedical Faculty, University Magdeburg665